candida
auri
emerg
multidrugresist
fungal
pathogen
sinc
first
report
c
auri
caus
healthcar
outbreak
around
world
often
involv
high
mortal
identif
c
auri
major
challeng
mani
common
convent
laboratori
method
accur
detect
earli
detect
implement
infect
control
practic
prevent
spread
aim
review
describ
recommend
detect
control
c
auri
healthcar
set
common
misidentif
base
frequent
use
yeast
identif
method
howev
effort
improv
c
auri
identif
method
made
substanti
progress
last
year
develop
highsalt
hightemperatur
enrich
culturebas
method
made
possibl
reliabl
isol
c
auri
complex
sampl
type
isol
obtain
identif
c
auri
effici
accomplish
matrixassist
laser
desorptionion
timeofflight
malditof
mass
spectrometri
malditof
identif
import
ensur
c
auri
refer
databas
bruker
biotyp
bruker
daltonik
gmbh
bremen
germani
vitek
ms
marci
letoil
franc
includ
c
auri
research
use
certain
version
fdaapprov
system
databas
malditof
avail
laboratori
reliabl
identifi
isol
sequenc
region
rdna
intern
transcrib
spacer
region
rdna
candida
auri
emerg
multidrugresist
fungu
caus
outbreak
invas
infect
healthcar
facil
around
world
c
auri
report
dozen
countri
six
contin
caus
outbreak
place
colombia
india
south
africa
spain
unit
state
http
wwwcdcgovfungalcandidaauristrackingcaurishtml
healthcar
facil
report
c
auri
outbreak
critic
ill
hospit
patient
high
crude
mortal
rate
risk
factor
c
auri
bloodstream
infect
bsi
similar
risk
factor
candida
speci
bsi
includ
recent
major
surgic
procedur
diabet
use
broadspectrum
antibiot
longterm
hospit
presenc
devic
includ
breath
tube
feed
tube
central
venou
cathet
risk
factor
candidemia
differ
popul
affect
exampl
unit
state
patient
neurolog
diseas
longterm
care
mani
devic
may
higher
risk
develop
invas
c
auri
infect
infect
occur
patient
age
infect
report
adult
abil
accur
identifi
c
auri
capac
implement
infect
control
practic
includ
environment
clean
critic
control
prevent
c
auri
outbreak
review
recommend
detect
control
c
auri
base
publish
literatur
experi
staff
us
center
diseas
control
prevent
cdc
identif
c
auri
isol
challeng
convent
phenotyp
method
yeast
identif
may
misidentifi
c
auri
isol
candida
haemulonii
candida
sake
rhodotorula
glutini
candida
speci
part
c
auri
databas
result
option
method
base
cdc
recommend
identif
c
auri
tabl
describ
confirmatori
test
cornmeal
agar
may
warrant
speci
c
guilliermondii
c
lusitania
c
parapsilosi
gener
make
pseudohypha
cornmeal
agar
absenc
hypha
pseudohypha
cornmeal
agar
rais
suspicion
c
auri
c
auri
abl
grow
c
high
salt
concentr
nacl
c
auri
coloni
appear
white
pink
red
coloni
distinguish
c
glabrata
c
auri
identifi
morpholog
alon
due
similar
candida
speci
supplement
modifi
media
shown
use
c
auri
screen
maldtof
sequenc
region
rdna
intern
transcrib
region
rdna
recommend
accur
identif
c
auri
phenotyp
yeast
identif
vitek
system
marci
letoil
franc
includ
c
auri
recent
softwar
upgrad
version
recent
studi
show
softwar
updat
limit
abil
correctli
identifi
c
auri
african
east
asian
clade
abl
accur
identifi
isol
south
american
clade
clinic
valid
vitek
system
upgrad
pend
henc
isol
identifi
use
system
c
auri
c
famata
speci
c
haemulonii
complex
confirm
malditof
dna
sequenc
valid
vitek
system
would
make
c
auri
isol
identif
access
wide
use
laboratori
beyond
improv
method
identifi
cultur
isol
number
cultureindepend
method
detect
c
auri
recent
describ
cultureindepend
method
highli
attract
result
obtain
hour
rather
day
allow
rapid
identif
colon
patient
time
write
clinic
evalu
three
cultureindepend
test
use
culturebas
gold
standard
publish
includ
taqman
quantit
pcr
qpcr
sybr
green
qpcr
magnet
reson
assay
perform
well
clinic
sensit
specif
close
exceed
unit
state
taqmanbas
qpcr
current
mostli
wide
use
cultureindepend
test
employ
c
auri
surveil
cdc
wadsworth
center
new
york
well
increas
number
antibiot
resist
laboratori
network
ar
lab
network
laboratori
recent
public
describ
success
adapt
taqman
qpcr
bd
max
system
becton
dickinson
nj
usa
autom
test
substanti
reduc
associ
labor
addit
promis
cultureindepend
test
develop
although
perform
clinic
sampl
yet
known
confirm
identif
c
auri
report
local
nation
public
health
author
infect
control
practic
prevent
transmiss
implement
facil
patient
resid
antifung
resist
c
auri
isol
vari
across
phylogenet
clade
multidrugresist
common
especi
among
isol
south
asia
clade
suscept
test
use
broth
microdilut
azol
echinocandin
gradient
diffus
azol
echinocandin
amphotericin
b
prefer
erron
suscept
result
report
c
auri
use
vitek
amphotericin
b
current
establish
minimum
inhibitori
concentr
mic
breakpoint
suscept
c
auri
isol
cdc
suggest
follow
tent
breakpoint
base
breakpoint
close
relat
candida
speci
expert
opinion
fluconazol
amphotericin
b
round
mic
found
use
etest
caspofungin
micafungin
anidulafungin
implement
infect
control
practic
crucial
control
c
auri
outbreak
healthcar
set
laps
infect
control
delay
recognit
case
delay
implement
infect
control
activ
may
result
rapid
transmiss
c
auri
among
patient
candida
consid
commens
organ
common
human
flora
sourc
infect
gener
autoinocul
oppos
patienttopati
transmiss
howev
c
auri
highli
transmiss
among
patient
perhap
due
procliv
persist
skin
colon
preliminari
data
suggest
patient
underw
placement
invas
medic
devic
procedur
central
venou
cathet
greater
risk
c
auri
bloodstream
infect
compar
patient
bloodstream
infect
caus
candida
speci
c
auri
commonli
colon
skin
cathet
may
provid
mean
fungu
enter
bloodstream
transmiss
c
auri
like
also
driven
abil
contamin
patient
care
environ
c
auri
found
healthcar
surfac
medic
equip
persist
surfac
long
period
prevent
spread
c
auri
depend
two
element
identif
case
implement
infect
control
precaut
identifi
case
minim
likelihood
transmiss
patient
infect
control
purpos
case
consid
occurr
either
c
auri
colon
infect
patient
follow
recommend
infect
control
summar
tabl
identif
case
c
auri
transmiss
whether
patient
c
auri
infect
colon
thu
infect
control
precaut
patient
c
auri
infect
colon
implement
practic
start
identif
case
basic
type
case
recognit
identif
incid
clinic
case
mean
c
auri
process
routin
clinic
specimen
candida
isol
obtain
steril
bodi
site
identifi
speci
level
addit
cdc
advis
identifi
candida
isol
recov
nonsteril
bodi
site
speci
level
c
auri
detect
facil
unit
patient
overnight
stay
healthcar
facil
outsid
unit
state
preced
year
especi
stay
countri
document
c
auri
transmiss
presenc
c
auri
bodi
site
repres
sourc
transmiss
trigger
implement
infect
control
precaut
patient
c
auri
colon
may
also
identifi
target
screen
screen
may
consid
patient
close
healthcar
contact
someon
c
auri
infect
colon
patient
overnight
healthcar
facil
stay
countri
outsid
unit
state
preced
year
especi
countri
document
c
auri
case
screen
patient
oversea
healthcar
exposur
c
auri
strongli
encourag
patient
infect
colon
carbapenemaseproduc
gramneg
bacteria
point
preval
screen
everi
patient
unit
floor
screen
time
may
employ
detect
unidentifi
colon
patient
evid
suspicion
transmiss
facil
screen
c
auri
commonli
done
use
composit
swab
patient
axilla
groin
region
site
determin
highyield
bodi
site
specimen
c
auri
isol
includ
nose
mouth
extern
ear
canal
urin
wound
rectum
axilla
groin
appear
consist
site
colon
although
evalu
need
hand
hygien
healthcar
personnel
hcp
practic
proper
frequent
hand
hygien
alcoholbas
hand
sanit
abh
soap
water
abh
effect
c
auri
prefer
hand
hygien
unless
hand
visibl
soil
case
handwash
soap
water
recommend
care
taken
ensur
enough
quantiti
abh
soap
towel
unclutt
sink
avail
order
facilit
hand
hygien
hcp
train
appropri
hand
hygien
techniqu
hire
retrain
regular
interv
import
monitor
hcp
adher
recommend
hand
hygien
practic
provid
personnel
feedback
regard
perform
transmissionbas
precaut
patient
acut
care
hospit
longterm
care
hospit
infect
colon
c
auri
place
contact
precaut
includ
place
patient
singl
room
use
appropri
person
protect
equip
ppe
restrict
patient
room
except
medic
necessari
procedur
whenev
possibl
patient
c
auri
infect
colon
hous
singlepati
room
limit
number
singl
room
avail
reserv
patient
highest
risk
transmiss
uncontain
secret
diarrhea
patient
colon
infect
c
auri
could
also
cohort
room
c
auri
patient
cohort
challeng
c
auri
patient
often
cocolon
differ
multidrugresist
organ
made
cohort
impract
mani
set
tabl
nurs
home
may
consid
use
less
restrict
precaut
patient
unit
experienc
ongo
transmiss
resid
uncontain
secret
excret
enhanc
barrier
precaut
recommend
situat
cdc
part
enhanc
barrier
precaut
ppe
use
bodi
fluid
exposur
anticip
well
high
contact
activ
dress
devic
care
chang
linen
requir
resid
care
activ
enhanc
barrier
precaut
resid
restrict
room
particip
group
activ
set
transmissionbas
precaut
continu
long
patient
colon
c
auri
typic
durat
c
auri
colon
remain
unknown
although
appear
protract
patient
healthcar
set
method
decolon
yet
establish
therefor
conserv
strategi
keep
patient
c
auri
infect
colon
transmissionbas
precaut
durat
healthcar
facil
stay
present
futur
indic
patient
transmissionbas
precaut
explain
ppe
need
clear
signag
place
outsid
patient
room
environment
clean
disinfect
extens
contamin
healthcar
environ
describ
facil
c
auri
outbreak
emphas
import
environment
clean
disinfect
environment
servic
staff
safe
remov
clean
visibl
organ
materi
eg
bodili
fluid
dirt
patient
care
area
disinfect
although
quaternari
ammonium
compound
qac
among
commonli
use
disinfect
healthcar
set
earli
studi
found
compound
ineffect
c
auri
howev
interpret
studi
complic
divers
methodolog
util
respons
environment
protect
agenc
epa
took
two
measur
improv
disinfect
guidanc
c
auri
first
cdc
epa
collabor
implement
interim
guidanc
c
auri
disinfect
use
eparegist
hospitalgrad
disinfect
known
effect
clostridioid
difficil
spore
data
avail
efficaci
disinfect
c
auri
simultan
epa
develop
releas
standard
quantit
disk
carrier
method
use
evalu
disinfect
efficaci
c
auri
disinfect
meet
log
reduct
perform
standard
defin
epa
acquir
formal
c
auri
master
label
kill
claim
recent
epa
approv
addit
c
auri
claim
master
label
oxivir
appli
readi
use
cleaner
wipe
epa
registr
respect
hydrogen
peroxid
base
cleaner
microkil
bleach
germicid
bleach
wipe
epa
registr
product
base
sodium
hypochlorit
addit
epa
also
approv
request
made
cdc
regard
section
emerg
exempt
feder
insecticid
fungicid
rodenticid
act
temporarili
permit
offlabel
use
seven
addit
disinfect
control
c
auri
action
support
efficaci
data
gener
cdc
person
commun
dj
sexton
cdc
expand
option
avail
healthcar
facil
work
control
c
auri
develop
repres
help
step
expand
number
disinfect
avail
control
c
auri
howev
disinfect
test
submiss
formal
c
auri
claim
epa
still
need
work
cdc
relat
public
group
reaffirm
earli
concern
qacbas
product
effect
also
indic
promis
addit
qac
chemistri
includ
alcoholbas
product
thorough
daili
clean
disinfect
special
attent
hightouch
surfac
bedrail
bedsid
tabl
need
patient
care
area
hous
patient
contact
precaut
c
auri
termin
clean
disinfect
perform
patient
move
care
area
perman
chemic
fog
vapor
hydrogen
peroxid
ozon
chlorin
dioxid
ultraviolet
light
ioniz
titanium
dioxideultraviolet
light
might
allow
thorough
disinfect
difficulttoreach
place
though
evalu
method
c
auri
need
import
close
monitor
adher
environment
clean
protocol
includ
protocol
clean
solut
prepar
contact
time
design
staff
member
assign
area
object
clean
daili
termin
clean
techniqu
routin
environment
test
c
auri
recommend
cultur
costli
timeintens
previou
investig
shown
c
auri
gener
detect
environ
c
auri
case
found
facil
use
machin
detect
adenosin
triphosph
atp
audit
clean
pathogenspecif
test
standard
environment
clean
audit
direct
observ
use
floresc
mark
determin
whether
surfac
clean
identifi
speci
candida
isol
steril
site
identifi
speci
candida
isol
nonsteril
site
clinic
indic
patient
resid
facil
unit
c
auri
case
identifi
patient
overnight
stay
facil
outsid
unit
state
past
year
especi
countri
c
auri
transmiss
consid
screen
patient
close
healthcar
contact
new
case
overnight
healthcar
stay
abroad
past
year
especi
countri
c
auri
case
strongli
consid
patient
also
infect
colon
carbapenemaseproduc
gram
neg
bacteria
transmiss
suspect
healthcar
facil
consid
expand
screen
individu
ward
case
identifi
infect
control
intervent
patient
c
auri
infect
colon
healthcar
personnel
hcp
practic
proper
frequent
hand
hygien
monitor
hcp
adher
hand
hygien
practic
provid
feedback
place
patient
infect
colon
c
auri
acut
care
hospit
longterm
acut
care
hospit
contact
precaut
nurs
home
consid
place
resid
c
auri
less
restrict
precaut
ie
cdc
enhanc
barrier
precaut
unless
uncontrol
secret
excret
ongo
transmiss
unit
facil
otherwis
use
contact
precaut
patient
appear
persist
colon
longterm
use
transmissionbas
precaut
healthcar
set
remain
place
indefinit
current
establish
protocol
decolon
patient
c
auri
highli
recommend
c
auri
infect
manag
consult
infecti
diseas
specialist
echinocandin
drug
recommend
initi
therapi
treatment
c
auri
infect
c
auri
isol
often
suscept
echinocandin
frequent
resist
two
main
antifung
drug
class
azol
polyen
antifung
treatment
manag
c
auri
infect
similar
candida
speci
infect
detail
patient
treatment
manag
summar
infecti
diseas
societi
america
idsa
clinic
practic
guidelin
manag
candidiasi
publish
conclus
evid
exist
regard
effect
protocol
decolon
patient
c
auri
outbreak
c
auri
unit
kingdom
bath
singleus
wipe
chlorhexidin
glucon
twice
daili
aqueou
chlorhexidin
formul
use
case
patient
ventil
support
also
receiv
mouth
wash
chlorhexidin
chlorhexidin
dental
gel
oral
nystatin
oral
oropharyng
colon
present
addit
chlorhexidin
impregn
protect
disk
use
central
vascular
cathet
exit
site
reduc
lineassoci
c
auri
bsi
despit
effort
c
auri
colon
transmiss
continu
facil
commun
person
c
auri
statu
key
ensur
infect
control
measur
carri
without
disrupt
patient
found
infect
colon
c
auri
appropri
commun
educ
provid
hcp
understand
infect
control
protocol
necessari
hcp
made
awar
infect
control
requir
necessari
care
patient
colon
infect
c
auri
given
suffici
resourc
facilit
adher
inform
c
auri
infect
colon
commun
whenev
patient
transfer
higher
lower
level
care
receiv
facil
abl
continu
infect
control
measur
c
auri
emerg
multidrugresist
pathogen
repres
seriou
threat
healthcar
set
global
emerg
pathogen
present
uniqu
issu
relat
rapid
transmiss
detect
capac
specif
environment
disinfect
need
howev
mani
infect
control
procedur
c
auri
repres
standard
fundament
practic
hand
hygien
transmissionbas
precaut
dilig
detect
infect
control
help
facil
prevent
control
outbreak
c
auri
author
contribut
author
particip
literatur
review
write
